Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1960 1
1961 1
1966 3
1967 1
1968 2
1969 3
1970 1
1971 3
1972 1
1973 2
1974 9
1975 7
1976 3
1977 3
1978 5
1979 2
1981 1
1982 2
1983 1
1984 5
1985 5
1986 3
1987 6
1988 4
1989 2
1990 2
1991 5
1992 2
1993 2
1994 1
1995 6
1996 1
1997 1
1998 1
1999 3
2000 5
2001 1
2002 2
2003 1
2006 3
2007 4
2008 6
2009 7
2010 5
2011 5
2012 8
2013 12
2014 13
2015 6
2016 15
2017 13
2018 12
2019 10
2020 9
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

225 results
Results by year
Filters applied: . Clear all
Page 1
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB. Carmeli Y, et al. Among authors: newell p. Lancet Infect Dis. 2016 Jun;16(6):661-673. doi: 10.1016/S1473-3099(16)30004-4. Epub 2016 Apr 20. Lancet Infect Dis. 2016. PMID: 27107460 Free article. Clinical Trial.
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
Das S, Li J, Riccobene T, Carrothers TJ, Newell P, Melnick D, Critchley IA, Stone GG, Nichols WW. Das S, et al. Among authors: newell p. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02187-18. doi: 10.1128/AAC.02187-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30670413 Free PMC article. Review.
Avibactam Pharmacokinetic/Pharmacodynamic Targets.
Nichols WW, Newell P, Critchley IA, Riccobene T, Das S. Nichols WW, et al. Among authors: newell p. Antimicrob Agents Chemother. 2018 May 25;62(6):e02446-17. doi: 10.1128/AAC.02446-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29610208 Free PMC article. Review.
Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.
Li J, Lovern M, Riccobene T, Carrothers TJ, Newell P, Das S, Talley AK, Tawadrous M. Li J, et al. Among authors: newell p. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02105-19. doi: 10.1128/AAC.02105-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015049 Free PMC article. Review.
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, Llorens L, Newell P, Pachl J. Mazuski JE, et al. Among authors: newell p. Clin Infect Dis. 2016 Jun 1;62(11):1380-1389. doi: 10.1093/cid/ciw133. Epub 2016 Mar 8. Clin Infect Dis. 2016. PMID: 26962078 Free PMC article. Clinical Trial.
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
Wagenlehner FM, Sobel JD, Newell P, Armstrong J, Huang X, Stone GG, Yates K, Gasink LB. Wagenlehner FM, et al. Among authors: newell p. Clin Infect Dis. 2016 Sep 15;63(6):754-762. doi: 10.1093/cid/ciw378. Epub 2016 Jun 16. Clin Infect Dis. 2016. PMID: 27313268 Free PMC article. Clinical Trial.
Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.
Bradley JS, Roilides E, Broadhurst H, Cheng K, Huang LM, MasCasullo V, Newell P, Stone GG, Tawadrous M, Wajsbrot D, Yates K, Gardner A. Bradley JS, et al. Among authors: newell p. Pediatr Infect Dis J. 2019 Sep;38(9):920-928. doi: 10.1097/INF.0000000000002395. Pediatr Infect Dis J. 2019. PMID: 31335570 Clinical Trial.
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM, Golub TR. Hoshida Y, et al. Among authors: newell p. Cancer Res. 2009 Sep 15;69(18):7385-92. doi: 10.1158/0008-5472.CAN-09-1089. Epub 2009 Sep 1. Cancer Res. 2009. PMID: 19723656 Free PMC article.
225 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page